Gastrointestinal disease and colonization by Helicobacter pylori were determined in 36 asymptomatic volunteers and 30 symptomatic individuals undergoing endoscopy and biopsy. Serum antibody immunoglobulin G (IgG) and IgA to H. pylori were measured by enzyme-linked immunosorbent assay. Serum antibody to a cytotoxin produced by H. pylori was detected with a neutralization assay. Serum IgG was 95% predictive of infection by H. pylori, and serum IgA was 88% predictive. Antibody to the cytotoxin was detected in 12 of 18 infected individuals. Antibody to the cytotoxin was a highly specific (96%), but not a very sensitive (67%), indicator of infection by H. pylori. The neutralization assay was 87% predictive of infection. These data confirm the diagnostic value of serum antibody to H. pylori for the detection of infection. The toxin-neutralizing activity of sera from individuals infected with H. pylori suggests that the cytotoxin is produced in vivo. It may therefore contribute to disease associated with H. pylori.
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Colonization of human gastric tissue by Helicobacter pylori (formerly Campylobacter pylori; 5) is associated with gastritis and peptic ulceration (1) . Bacteria colonize the gastric mucus layer and induce gastric inflammation with depletion of gastric mucus (13) . The mechanism by which H. pylori produces gastric disease is not clear.
A cytotoxic activity is produced in vitro by H. pylori. Culture filtrates of broth-grown bacteria induce intracellular vacuolation of several cultured mammalian cell types (9) . Fifty-seven percent of over 200 strains of H. pylori tested produced this activity. Intracellular vacuolation of gastric epithelial cells in biopsy specimens of gastritis patients (16) and experimentally infected germfree piglets (4) was reported. Vacuolation may be a nonspecific indicator of unhealthy or dying cells (3) or may be specifically induced by the toxin. Production of the cytotoxin in vivo or its contribution to disease associated with H. pylori has not been demonstrated.
Serum antibody to H. pylori is detectable in individuals infected with the bacterium (2, 8, 1$). Measurement of specific antibody has diagnostic value for the detection of infection by H. pylori (6, 10, 12, 14) . However, the utility of serological techniques to indicate the outcome of antimicrobial therapy for infection has not been clearly demonstrated.
The aim of this work was to determine whether the cytotoxin of H. pylori detected in vitro stimulates an immune response in infected individuals. The ultimate goal is to determine whether the cytotoxin is produced in vivo during infection and, therefore, whether it may be relevant to gastroduodenal disease associated with H. pylori. Assays for cytotoxin and neutralization. Cytotoxin was assayed as previously described (9) (11 of 14) having neutralization titers between 1/2 and 1/8. Neutralization could not be determined for three of the sera because of their cytolytic effect on HeLa cells which precluded observation of intracellular vacuolation.
MATERIALS AND METHODS
Antibody to the cytotoxin, as measured by neutralization, correlated well with the presence of antibody to the bacterium, measured by ELISA (Table 2) . Of 19 serum samples, 12 (63%) with antibody to the bacterium contained antibody to the cytotoxin. Of 44 samples, 42 (95%) without antibody to the bacterium did not contain antibody to the cytotoxin. In the sera of two individuals from whom H. pylori was not cultured and in which antibody to the bacterium was not detected, antibody to the cytotoxin was detected.
The diagnostic value of antibody to the cytotoxin for infection is shown in Table 3 . Detection of antibody specific for the cytotoxin, as measured by neutralization, was 67% sensitive and 96% specific for infection by H. pylori.
Cytotoxin. Production of cytotoxin in vitro by isolates from the patients was measured directly by assessing the ability of broth culture filtrate to induce vacuolation of HeLa cells. This was compared with the ability of serum from the same patient to neutralize a standard preparation of cytotoxin. Neutralization of cytotoxin by serum from a patient correlated poorly with production of cytotoxin by the isolate of that patient (Table 4 ). For 14 patients studied, concordance was 50%. Considering both measures, evidence for the production of cytotoxin in vivo was present for 11 of 14 patients (79%). (6, 10, 12, 14) .
The presence of antibody to the cytotoxin, measured by neutralization, correlated well with the presence of antibody to the bacterium, measured by ELISA. This is consistent with neutralization of cytotoxic activity by specific antibody, as opposed to destruction of the cytotoxin by a nonspecific mechanism, such as degradation by a serum protease. Neutralization of cytotoxin by the sera of individuals infected with H. pylori suggests that the cytotoxin is produced in vivo. It may, therefore, be involved in the production of disease associated with H. pylori. Correlation of cytotoxin with either the symptoms or clinical outcome of disease is of interest.
Antibody to the cytotoxin was a highly specific indicator of infection by H. pylori, although it was not a sensitive indicator of infection. Measurement of antibody to the cytotoxin was less predictive of infection than was measurement of antibody to the bacterium. These results might be expected on the basis of the finding that not all isolates produce the cytotoxin in vitro. The neutralization assay is subjective and takes longer to complete than the ELISA. In addition, some sera were not evaluable by neutralization because of their effects on HeLa cells. Detection of antibody to the cytotoxin offers no advantage over detection of antibody to the bacterium as an indicator of infection by H. pylori. In 14 individuals studied, neutralization of the cytotoxin correlated poorly with production of the cytotoxin by the homologous isolate. Antibody to the cytotoxin was frequently detected in patients from whom a nontoxigenic Antibody to H. pylori and to the cytotoxin in serum was investigated in these studies. Secretory antibody specific for H. pylori in infected individuals has been demonstrated (15) . Whether secretory antibody specific for the cytotoxin is also produced is not currently known.
The question of how best to measure involvement of cytotoxin in disease associated with H. pylori remains. Cytotoxin from some isolates of H. pylori is detectable only after concentration of the broth culture filtrate (9) . This suggests that direct assay for the cytotoxin in vitro is not very sensitive. Demonstration of antibody to the cytotoxin by neutralization is an indirect measure of the involvement of cytotoxin in infection. Use of both approaches suggests that more isolates of H. pylori produce the cytotoxin than is suggested by direct assay alone. A sensitive molecular probe for the cytotoxin or for its structural gene is required to determine accurately the percentage of isolates producing the cytotoxin.
